WeVote
Log In

Bill

Bill

SB 306

Workers' Compensation - Prescription Drug and Pharmaceutical Services - Reimbursements

2025 Regular Session Introduced by Pam Beidle

SB 306 adjusts workers' compensation reimbursement rates for prescription drugs and pharmaceutical services in Maryland, affecting employer costs and injured worker medication access.

Hearing 3/26 at 1:00 p.m.
0
WeVote Research Nonpartisan
Bill Summary · SB 306

Legislative bill overview

SB 306 modifies Maryland's workers' compensation system to adjust how prescription drugs and pharmaceutical services are reimbursed. The bill establishes new reimbursement rates or methodologies for medications and related services provided to injured workers under workers' compensation coverage.

Why is this important

Workers' compensation drug costs have risen significantly across most states, affecting both employer insurance premiums and injured workers' access to necessary medications. This bill directly impacts the cost structure for businesses carrying workers' comp insurance and determines what pharmaceutical treatments injured workers can realistically access through their benefits.

Potential points of contention

  • Cost allocation: Whether new reimbursement rates adequately compensate pharmacies and drug providers, or shift costs unfairly toward employers and insurers
  • Worker access: Whether adjustments to reimbursement methodology might limit injured workers' access to certain medications or create barriers to filling prescriptions
  • Industry impact: How changes affect small businesses with workers' compensation insurance versus larger self-insured employers, and competitive positioning of in-state versus out-of-state pharmaceutical providers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.